Literature DB >> 21287671

Mood and nonmood components of perceived stress and exacerbation of Crohn's disease.

Rafael J A Cámara1, Alain M Schoepfer, Valérie Pittet, Stefan Begré, Roland von Känel.   

Abstract

BACKGROUND: Diverse psychological factors are involved in the pathophysiology of stress. In order to devise effective intervention strategies, it is important to elucidate which factors play the most important role in the association between psychological stress and exacerbation of Crohn's disease (CD). We hypothesized that the association between perceived stress and exacerbation of CD would remain after removal of mood and anxiety components, which are largely involved in stress perception.
METHODS: In all, 468 adults with CD were recruited and followed in different hospitals and private practices of Switzerland for 18 months. At inclusion, patients completed the Perceived Stress Questionnaire and anxiety and depression were assessed using the Hospital Anxiety and Depression Scale. During the follow-up, gastroenterologists assessed whether patients presented with a CD exacerbation. By means of binary logistic regression analysis, we estimated the factor by which one standard deviation of perceived stress would increase the odds of exacerbation of CD with and without controlling for anxiety and depression.
RESULTS: The odds of exacerbation of CD increased by 1.85 times (95% confidence interval 1.43-2.40, P < 0.001) for 1 standard deviation of perceived stress. After removing the anxiety and depression components, the residuals of perceived stress were no longer associated with exacerbation of CD.
CONCLUSIONS: The association between perceived stress and exacerbation of CD was fully attributable to the mood components, specifically anxiety and depression. Future interventional studies should evaluate the treatment of anxiety and depression as a strategy for potential prevention of CD exacerbations.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21287671     DOI: 10.1002/ibd.21623

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  19 in total

Review 1.  Inflammatory bowel disease: pathogenesis.

Authors:  Yi-Zhen Zhang; Yong-Yu Li
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 2.  Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Authors:  Iwona Krela-Kaźmierczak; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielińska; Liliana Łykowska-Szuber; Aleksandra Szymczak-Tomczak; Agnieszka Zawada; Anna Maria Rychter; Alicja Ewa Ratajczak; Kinga Skoracka; Dorota Skrzypczak; Emilia Marcinkowska; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 3.  Environmental triggers for inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2013-01

4.  Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.

Authors:  Bharati Kochar; Christopher F Martin; Michael D Kappelman; Brennan M Spiegel; Wenli Chen; Robert S Sandler; Millie D Long
Journal:  Am J Gastroenterol       Date:  2017-08-29       Impact factor: 10.864

5.  Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease.

Authors:  A N Ananthakrishnan; V S Gainer; R G Perez; T Cai; S-C Cheng; G Savova; P Chen; P Szolovits; Z Xia; P L De Jager; S Y Shaw; S Churchill; E W Karlson; I Kohane; R H Perlis; R M Plenge; S N Murphy; K P Liao
Journal:  Aliment Pharmacol Ther       Date:  2013-01-07       Impact factor: 8.171

Review 6.  Environmental risk factors for inflammatory bowel diseases: a review.

Authors:  Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2014-09-10       Impact factor: 3.199

7.  Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability.

Authors:  Sinan Guloksuz; Marieke Wichers; Gunter Kenis; Maurice G V M Russel; Annick Wauters; Robert Verkerk; Baer Arts; Jim van Os
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

8.  Stress as a Trigger for Relapses in IBD: A Case-Crossover Study.

Authors:  Susanna Jaghult; Fredrik Saboonchi; Jette Moller; Unn-Britt Johansson; Regina Wredling; Marjo Kapraali
Journal:  Gastroenterology Res       Date:  2013-03-09

9.  Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Authors:  Lena Oxelmark; Annelie Lindberg; Robert Löfberg; Berit Sternby; Anders Eriksson; Sven Almer; Ragnar Befrits; Bjöörn Fossum; Per Karlén; Olle Broström; Curt Tysk
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-11       Impact factor: 2.566

10.  The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time.

Authors:  Ruth Ann Marrie; Lesley A Graff; John D Fisk; Scott B Patten; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2021-07-27       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.